semaglutide
Showing 1 - 25 of 191
Semaglutide Use in Acute Pulmonary Embolism
Completed
- Pulmonary Embolism
- Semaglutide
-
London, United KingdomColm McCabe
Nov 3, 2023
Type 2 Diabetes Trial in Jinan (Semaglutide, Semaglutide Pen Injector [Ozempic])
Not yet recruiting
- Type 2 Diabetes
- Semaglutide
- Semaglutide Pen Injector [Ozempic]
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Jul 11, 2023
Alcohol Use Disorder Trial in Tulsa (Semaglutide, Placebo)
Not yet recruiting
- Alcohol Use Disorder
- Semaglutide
- Placebo
-
Tulsa, OklahomaOSU Biomedical Imaging Center
Jun 5, 2023
Healthy Participants Trial in Neuss (Semaglutide)
Not yet recruiting
- Healthy Participants
- Semaglutide
-
Neuss, GermanyNovo Nordisk Investigational Site
Aug 10, 2023
Addiction, Alcohol Use Disorder Trial in Baltimore (Take Control, Semaglutide)
Recruiting
- Addiction
- Alcohol Use Disorder
- Take Control
- Semaglutide
-
Baltimore, MarylandNational Institute on Drug Abuse
Sep 2, 2023
Non-alcoholic Steatohepatitis Trial in Montreal (NNC0194-0499, Semaglutide, NNC0194-0499/Semaglutide A (40/3.20 mg/mL))
Not yet recruiting
- Non-alcoholic Steatohepatitis
- NNC0194-0499
- +3 more
-
Montreal, Quebec, CanadaNovo Nordisk Investigational Site
Mar 9, 2023
Diabetic Kidney Disease, Type 1 Diabetes Trial (Semaglutide, Placebo)
Not yet recruiting
- Diabetic Kidney Disease
- Type 1 Diabetes
- Semaglutide
- Placebo
- (no location specified)
Apr 18, 2023
Cystic Fibrosis, Cystic Fibrosis-related Diabetes Trial in Minneapolis (Semaglutide)
Not yet recruiting
- Cystic Fibrosis
- Cystic Fibrosis-related Diabetes
- Semaglutide
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 15, 2023
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese Trial (Semaglutide)
Not yet recruiting
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- Obese
- Semaglutide
- (no location specified)
Apr 6, 2023
Fibrosis, Liver, Type 2 Diabetes in Obese, Non-Alcoholic Fatty Liver Disease Trial in La Jolla (Semaglutide, Placebo)
Recruiting
- Fibrosis, Liver
- +2 more
- Semaglutide
- Placebo
-
La Jolla, CaliforniaUniversity of California, San Diego
Aug 25, 2023
Healthy Volunteers Trial in Berlin (Semaglutide, Dapagliflozin, Semaglutide/dapagliflozin)
Recruiting
- Healthy Volunteers
- Semaglutide
- +2 more
-
Berlin, Brandenburg, GermanyNovo Nordisk Investigational Site
Aug 10, 2022
ive Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Active, not recruiting
- Diabetes
- Semaglutide
- DPP-4 inhibitor
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 3, 2023
Diabetes, Type 2 Trial in Austria, Denmark, Sweden (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Graz, Austria
- +3 more
Dec 5, 2022
Healthy Participants Trial in Montreal (Semaglutide)
Recruiting
- Healthy Participants
- Semaglutide
-
Montreal, Quebec, CanadaNovo Nordisk Investigational Site
Oct 18, 2023
Type 2 Diabetes, End Stage Renal Disease on Dialysis Trial in Chapel Hill (Semaglutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- End Stage Renal Disease on Dialysis
- Semaglutide
- Placebo
-
Chapel Hill, North CarolinaUniversity of North Carolina
Sep 11, 2023
Healthy Volunteers, Diabetes, Type 2, Overweight Trial in Groningen (Semaglutide, Dulaglutide)
Completed
- Healthy Volunteers
- +3 more
- Semaglutide
- Dulaglutide
-
Groningen, NetherlandsNovo Nordisk Investigational Site
Nov 4, 2022
Acute Ischemic Stroke Trial in Aarhus (Semaglutide, Standard care)
Not yet recruiting
- Acute Ischemic Stroke
- Semaglutide
- Standard care
-
Aarhus, DenmarkAarhus University Hospital
Dec 9, 2022
Healthy, Obesity Trial (BI 1820237, semaglutide, Placebo)
Not yet recruiting
- Healthy
- Obesity
- BI 1820237
- +3 more
- (no location specified)
Mar 6, 2023
Overweight, Obesity Trial in China (Semaglutide, Semaglutide Placebo)
Not yet recruiting
- Overweight
- Obesity
- Semaglutide
- Semaglutide Placebo
-
Beijing, Beijing, China
- +14 more
May 26, 2023
Alzheimer, Mild Cognitive Impairment, Metabolic Syndrome Trial in Ramat Gan (Semaglutide, Intranasal insulin, Semaglutide )
Not yet recruiting
- Alzheimer Disease
- +2 more
- Semaglutide
- +3 more
-
Ramat Gan, IsraelJoseph Sagol Neuroscience center, Sheba Medical Center
Oct 3, 2023
Cardiomyopathy, Heart Failure With Preserved Ejection Fraction (HFpEF), Obesity Trial in Rochester (Semaglutide, Placebo,
Recruiting
- Cardiomyopathy
- +2 more
- Semaglutide
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 3, 2023
Diabetes, Type 2 Trial in Beijing (NNC0480 0389, Semaglutide)
Recruiting
- Diabetes Mellitus, Type 2
- NNC0480 0389
- Semaglutide
-
Beijing, Beijing, ChinaNovo Nordisk Investigational Site
Aug 11, 2022
Diabetes, Type 2 Trial in Santiago, Región Metropolitana (Semaglutide)
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
-
Santiago, Región Metropolitana, Chile
- +2 more
Sep 9, 2022
(rPMS) Study of Rybelsus to Evaluate Safety and Effectiveness in
Not yet recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- (no location specified)
Jan 27, 2023